Header Logo

Jill Ann Macoska PhD

TitleAdjunct Professor
InstitutionUMass Chan Medical School
DepartmentMedicine
AddressUniversity of Massachusetts Boston .
100 Morrissey Boulevard
Boston MA 02125
Phone617-287-5783
vCardDownload vCard
    Other Positions
    InstitutionT.H. Chan School of Medicine
    DepartmentMedicine


    Collapse Biography 
    Collapse education and training
    Kent State University, Kent, OH, United StatesBAPhysical Anthropology
    City University of New York, New York, NY, United StatesMPHILChemistry/Biochemistry
    City University of New York, New York, NY, United StatesPHDChemistry/Biochemistry

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hashemi Gheinani A, Sack BS, Bigger-Allen A, Thaker H, Atta H, Lambrinos G, Costa K, Doyle C, Gharaee-Kermani M, Patalano S, Piper M, Cotellessa JF, Vitko D, Li H, Kadayil Prabhakaran M, Cristofaro V, Froehlich J, Lee RS, Yang W, Sullivan MP, Macoska JA, Adam RM. Multiomics analysis unveils an inosine-sensitive DNA damage response in neurogenic bladder after spinal cord injury. JCI Insight. 2025 Jun 23; 10(12). PMID: 40338665.
      Citations:    
    2. Labaf M, Han W, Zhang S, Liu M, Patten ND, Li M, Patalano S, Macoska JA, Balk SP, Han D, Zarringhalam K, Cai C. Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient Cells. Mol Cancer Ther. 2025 May 02; 24(5):772-783. PMID: 40116305.
      Citations:    
    3. Berger N, Kugler B, Han D, Li M, Nguyen P, Anderson M, Patalano-Salsman S, Zhang S, Macoska J, Cai C, Zou K. Voluntary Exercise Attenuates Tumor Growth in a Preclinical Model of Castration-Resistant Prostate Cancer. Med Sci Sports Exerc. 2025 Aug 01; 57(8):1732-1742. PMID: 40173332.
      Citations:    
    4. Wang Z, Townley SL, Zhang S, Liu M, Li M, Labaf M, Patalano S, Venkataramani K, Siegfried KR, Macoska JA, Han D, Gao S, Risbridger GP, Taylor RA, Lawrence MG, He HH, Selth LA, Cai C. FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer. Nat Commun. 2024 Jun 08; 15(1):4914. PMID: 38851846.
      Citations:    
    5. Han D, Labaf M, Zhao Y, Owiredu J, Zhang S, Patel K, Venkataramani K, Steinfeld JS, Han W, Li M, Liu M, Wang Z, Besschetnova A, Patalano S, Mulhearn MJ, Macoska JA, Yuan X, Balk SP, Nelson PS, Plymate SR, Gao S, Siegfried KR, Liu R, Stangis MM, Foxa G, Czernik PJ, Williams BO, Zarringhalam K, Li X, Cai C. Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs. J Clin Invest. 2024 Apr 30; 134(11). PMID: 38687617.
      Citations:    
    6. Macoska JA. The use of beta-sitosterol for the treatment of prostate cancer and benign prostatic hyperplasia. Am J Clin Exp Urol. 2023; 11(6):467-480. PMID: 38148931.
      Citations:    
    7. Arriojas A, Patalano S, Macoska J, Zarringhalam K. A Bayesian noisy logic model for inference of transcription factor activity from single cell and bulk transcriptomic data. NAR Genom Bioinform. 2023 Dec; 5(4):lqad106. PMID: 38094309.
      Citations:    
    8. Gheinani AH, Sack BS, Bigger-Allen A, Thaker H, Atta H, Lambrinos G, Costa K, Doyle C, Gharaee-Kermani M, Patalano S, Piper M, Cotellessa JF, Vitko D, Li H, Prabhakaran MK, Cristofaro V, Froehlich J, Lee RS, Yang W, Sullivan MP, Macoska JA, Adam RM. Integrated omics analysis unveils a DNA damage response to neurogenic injury. bioRxiv. 2023 Dec 10. PMID: 38106029.
      Citations:    
    9. D'Arcy Q, Sarna-McCarthy M, Bowen D, Soto FO, Zarringhalam K, Macoska JA. Beta-Sitosterol Alters Collagen Distribution in Prostate Fibroblasts. J Diet Suppl. 2024; 21(3):313-326. PMID: 37933457.
      Citations:    
    10. Besschetnova A, Han W, Liu M, Gao Y, Li M, Wang Z, Labaf M, Patalano S, Venkataramani K, Muriph RE, Macoska JA, Siegfried KR, Evans J, Balk SP, Gao S, Han D, Cai C. Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression. Cancer Res Commun. 2023 08; 3(8):1716-1730. PMID: 37663929.
      Citations:    
    11. Wang Z, Petricca J, Liu M, Zhang S, Chen S, Li M, Besschetnova A, Patalano S, Venkataramani K, Siegfried KR, Macoska JA, Han D, Gao S, Vedadi M, Arrowsmith CH, He HH, Cai C. SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1. Proc Natl Acad Sci U S A. 2023 08 15; 120(33):e2220472120. PMID: 37549269.
      Citations:    
    12. Li M, Liu M, Han W, Wang Z, Han D, Patalano S, Macoska JA, Balk SP, He HH, Corey E, Gao S, Cai C. LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer. Cancer Res. 2023 05 15; 83(10):1684-1698. PMID: 36877164.
      Citations:    
    13. Arriojas A, Patalano S, Macoska J, Zarringhalam K. A Bayesian Noisy Logic Model for Inference of Transcription Factor Activity from Single Cell and Bulk Transcriptomic Data. bioRxiv. 2023 May 05. PMID: 37205561.
      Citations:    
    14. Labaf M, Li M, Ting L, Karno B, Zhang S, Gao S, Patalano S, Macoska JA, Zarringhalam K, Han D, Cai C. Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2. Front Oncol. 2022; 12:1021845. PMID: 36408179.
      Citations:    
    15. D'Arcy Q, Gharaee-Kermani M, Zhilin-Roth A, Macoska JA. The IL-4/IL-13 signaling axis promotes prostatic fibrosis. PLoS One. 2022; 17(10):e0275064. PMID: 36201508.
      Citations:    
    16. Han W, Liu M, Han D, Toure AA, Li M, Besschetnova A, Wang Z, Patalano S, Macoska JA, Lam HM, Corey E, He HH, Gao S, Balk SP, Cai C. Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer. Mol Ther. 2022 04 06; 30(4):1628-1644. PMID: 35121110.
      Citations:    
    17. Han W, Liu M, Han D, Li M, Toure AA, Wang Z, Besschetnova A, Patalano S, Macoska JA, Gao S, He HH, Cai C. RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition. Oncogene. 2022 Feb; 41(6):852-864. PMID: 34975152.
      Citations:    
    18. Tantiwetrueangdet A, Panvichian R, Sornmayura P, Leelaudomlipi S, Macoska JA. PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues. BMC Cancer. 2021 Mar 20; 21(1):295. PMID: 33743635.
      Citations:    
    19. Han D, Owiredu JN, Healy BM, Li M, Labaf M, Steinfeld JS, Patalano S, Gao S, Liu M, Macoska JA, Zarringhalam K, Siegfried KR, Yuan X, Rebbeck TR, Cai C. Susceptibility-Associated Genetic Variation in NEDD9 Contributes to Prostate Cancer Initiation and Progression. Cancer Res. 2021 07 15; 81(14):3766-3776. PMID: 33632899.
      Citations:    
    20. Gao S, Chen S, Han D, Wang Z, Li M, Han W, Besschetnova A, Liu M, Zhou F, Barrett D, Luong MP, Owiredu J, Liang Y, Ahmed M, Petricca J, Patalano S, Macoska JA, Corey E, Chen S, Balk SP, He HH, Cai C. Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer. Nat Genet. 2020 10; 52(10):1011-1017. PMID: 32868907.
      Citations:    
    21. Ruetten H, Wegner KA, Kennedy CL, Turco A, Zhang HL, Wang P, Sandhu J, Sandhu S, Morkrid J, Wang Z, Macoska J, Peterson RE, Bjorling DE, Ricke WA, Marker PC, Vezina CM. Impact of sex, androgens, and prostate size on C57BL/6J mouse urinary physiology: urethral histology. Am J Physiol Renal Physiol. 2020 03 01; 318(3):F617-F627. PMID: 31904290.
      Citations:    
    22. Farahmand S, O'Connor C, Macoska JA, Zarringhalam K. Causal Inference Engine: a platform for directional gene set enrichment analysis and inference of active transcriptional regulators. Nucleic Acids Res. 2019 12 16; 47(22):11563-11573. PMID: 31701125.
      Citations:    
    23. Ruetten H, Wegner KA, Zhang HL, Wang P, Sandhu J, Sandhu S, Morkrid J, Mueller B, Wang Z, Macoska J, Peterson RE, Bjorling DE, Ricke WA, Marker PC, Vezina CM. Insight and Resources From a Study of the "Impact of Sex, Androgens, and Prostate Size on C57BL/6J Mouse Urinary Physiology. Toxicol Pathol. 2019 12; 47(8):1038-1042. PMID: 31662055.
      Citations:    
    24. Liu TT, Rodgers AC, Nicholson TM, Macoska JA, Marker PC, Vezina CM, Bjorling DE, Roldan-Alzate A, Hernando D, Lloyd GL, Hacker TA, Ricke WA. Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing. J Vis Exp. 2019 08 14; (150). PMID: 31475976.
      Citations:    
    25. Ruetten H, Wegner KA, Zhang HL, Wang P, Sandhu J, Sandhu S, Mueller B, Wang Z, Macoska J, Peterson RE, Bjorling DE, Ricke WA, Marker PC, Vezina CM. Impact of sex, androgens, and prostate size on C57BL/6J mouse urinary physiology: functional assessment. Am J Physiol Renal Physiol. 2019 10 01; 317(4):F996-F1009. PMID: 31390231.
      Citations:    
    26. Gao S, Chen S, Han D, Barrett D, Han W, Ahmed M, Patalano S, Macoska JA, He HH, Cai C. Forkhead domain mutations in FOXA1 drive prostate cancer progression. Cell Res. 2019 Sep; 29(9):770-772. PMID: 31324883.
      Citations:    
    27. Wang Z, Guzman EC, Nimunkar A, Keil KP, Vezina CM, Ricke WA, Macoska J, Bjorling DE. Void sorcerer: an open source, open access framework for mouse uroflowmetry. Am J Clin Exp Urol. 2019; 7(3):170-177. PMID: 31317056.
      Citations:    
    28. Macoska JA, Uchtmann KS, Leverson GE, McVary KT, Ricke WA. Prostate Transition Zone Fibrosis is Associated with Clinical Progression in the MTOPS Study. J Urol. 2019 12; 202(6):1240-1247. PMID: 31188728.
      Citations:    
    29. Macoska JA, Wang Z, Virta J, Zacharias N, Bjorling DE. Inhibition of the CXCL12/CXCR4 axis prevents periurethral collagen accumulation and lower urinary tract dysfunction in vivo. Prostate. 2019 05; 79(7):757-767. PMID: 30811623.
      Citations:    
    30. Zhou F, Gao S, Han D, Han W, Chen S, Patalano S, Macoska JA, He HH, Cai C. TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells. Oncogene. 2019 05; 38(22):4397-4411. PMID: 30718921.
      Citations:    
    31. Almanza D, Gharaee-Kermani M, Zhilin-Roth A, Rodriguez-Nieves JA, Colaneri C, Riley T, Macoska JA. Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature. Dig Dis Sci. 2019 05; 64(5):1257-1269. PMID: 30519850.
      Citations:    
    32. Affas S, Sch?fer FM, Algarrahi K, Cristofaro V, Sullivan MP, Yang X, Costa K, Sack B, Gharaee-Kermani M, Macoska JA, Gundogdu G, Seager C, Estrada CR, Mauney JR. Augmentation Cystoplasty of Diseased Porcine Bladders with Bi-Layer Silk Fibroin Grafts. Tissue Eng Part A. 2019 06; 25(11-12):855-866. PMID: 30191762.
      Citations:    
    33. Wegner KA, Abler LL, Oakes SR, Mehta GS, Ritter KE, Hill WG, Zwaans BM, Lamb LE, Wang Z, Bjorling DE, Ricke WA, Macoska J, Marker PC, Southard-Smith EM, Eliceiri KW, Vezina CM. Void spot assay procedural optimization and software for rapid and objective quantification of rodent voiding function, including overlapping urine spots. Am J Physiol Renal Physiol. 2018 10 01; 315(4):F1067-F1080. PMID: 29972322.
      Citations:    
    34. Patalano S, Rodr?guez-Nieves J, Colaneri C, Cotellessa J, Almanza D, Zhilin-Roth A, Riley T, Macoska J. CXCL12/CXCR4-Mediated Procollagen Secretion Is Coupled To Cullin-RING Ubiquitin Ligase Activation. Sci Rep. 2018 02 22; 8(1):3499. PMID: 29472636.
      Citations:    
    35. Macoska JA. Androgen receptor variants: another twist in the plot. Oncotarget. 2017 03 07; 8(10):16100. PMID: 28184022.
      Citations:    
    36. Han D, Gao S, Valencia K, Owiredu J, Han W, de Waal E, Macoska JA, Cai C. A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer. Oncotarget. 2017 Jan 24; 8(4):6796-6808. PMID: 28036278.
      Citations:    
    37. Shoskes DA, Macoska JA. Preface to the human microbiome in urologic health and disease. Ann Transl Med. 2017 Jan; 5(2):27. PMID: 28217692.
      Citations:    
    38. Gao S, Gao Y, He HH, Han D, Han W, Avery A, Macoska JA, Liu X, Chen S, Ma F, Chen S, Balk SP, Cai C. Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein. Cell Rep. 2016 10 18; 17(4):966-976. PMID: 27760327.
      Citations:    
    39. Hao L, Greer T, Page D, Shi Y, Vezina CM, Macoska JA, Marker PC, Bjorling DE, Bushman W, Ricke WA, Li L. In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms. Sci Rep. 2016 08 09; 6:30869. PMID: 27502322.
      Citations:    
    40. Rodr?guez-Nieves JA, Patalano SC, Almanza D, Gharaee-Kermani M, Macoska JA. CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion through Non-Canonical EGFR/MEK/ERK Signaling. PLoS One. 2016; 11(7):e0159490. PMID: 27434301.
      Citations:    
    41. Gharaee-Kermani M, Moore BB, Macoska JA. Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion. PLoS One. 2016; 11(7):e0158357. PMID: 27367854.
      Citations:    
    42. Begley LA, Kasina S, Shah RB, Macoska JA. Signaling mechanisms coupled to CXCL12/CXCR4-mediated cellular proliferation are PTEN-dependent. Am J Clin Exp Urol. 2015; 3(2):91-9. PMID: 26309898.
      Citations:    
    43. Gharaee-Kermani M, Mehra R, Robinson DR, Wei JT, Macoska JA. Complex cellular composition of solitary fibrous tumor of the prostate. Am J Pathol. 2014 Mar; 184(3):732-9. PMID: 24434011.
      Citations:    
    44. Gharaee-Kermani M, Macoska JA. Promising molecular targets and biomarkers for male BPH and LUTS. Curr Urol Rep. 2013 Dec; 14(6):628-37. PMID: 23913202.
      Citations:    
    45. Rodriguez-Nieves JA, Macoska JA. Prostatic fibrosis, lower urinary tract symptoms, and BPH. Nat Rev Urol. 2013 Sep; 10(9):546-50. PMID: 23857178.
      Citations:    
    46. Gharaee-Kermani M, Rodriguez-Nieves JA, Mehra R, Vezina CA, Sarma AV, Macoska JA. Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse model. Prostate. 2013 Jul; 73(10):1123-33. PMID: 23532836.
      Citations:    
    47. Macoska J. Prostatic Fibrosis Is Associated With Lower Urinary Tract Symptoms. J Urol. 2012 12 19. PMID: 23261479.
      Citations:    
    48. Chen W, Weng S, Zhang F, Allen S, Li X, Bao L, Lam RH, Macoska JA, Merajver SD, Fu J. Nanoroughened surfaces for efficient capture of circulating tumor cells without using capture antibodies. ACS Nano. 2013 Jan 22; 7(1):566-75. PMID: 23194329.
      Citations:    
    49. Gharaee-Kermani M, Kasina S, Moore BB, Thomas D, Mehra R, Macoska JA. CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis. PLoS One. 2012; 7(11):e49278. PMID: 23173053.
      Citations:    
    50. Agarwal M, He C, Siddiqui J, Wei JT, Macoska JA. CCL11 (eotaxin-1): a new diagnostic serum marker for prostate cancer. Prostate. 2013 May; 73(6):573-81. PMID: 23059958.
      Citations:    
    51. Ma J, Gharaee-Kermani M, Kunju L, Hollingsworth JM, Adler J, Arruda EM, Macoska JA. Prostatic fibrosis is associated with lower urinary tract symptoms. J Urol. 2012 Oct; 188(4):1375-81. PMID: 22906651.
      Citations:    
    52. Kasina S, Macoska JA. The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor. Mol Cell Endocrinol. 2012 Apr 04; 351(2):249-63. PMID: 22245379.
      Citations:    
    53. Ricke WA, Macoska JA, Cunha GR. Developmental, cellular and molecular biology of benign prostatic hyperplasia. Differentiation. 2011 Nov-Dec; 82(4-5):165-7. PMID: 21880411.
      Citations:    
    54. Sottnik JL, Zhang J, Macoska JA, Keller ET. The PCa Tumor Microenvironment. Cancer Microenviron. 2011 Dec; 4(3):283-97. PMID: 21728070.
      Citations:    
    55. Macoska JA. Chemokines and BPH/LUTS. Differentiation. 2011 Nov-Dec; 82(4-5):253-60. PMID: 21600689.
      Citations:    
    56. Sethi S, Macoska J, Chen W, Sarkar FH. Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis. Am J Transl Res. 2010 Oct 23; 3(1):90-9. PMID: 21139809.
      Citations:    
    57. McDowell KL, Begley LA, Mor-Vaknin N, Markovitz DM, Macoska JA. Leukocytic promotion of prostate cellular proliferation. Prostate. 2010 Mar 01; 70(4):377-89. PMID: 19866464.
      Citations:    
    58. Macoska JA, Adsule S, Tantivejkul K, Wang S, Pienta KJ, Lee CT. -(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro. Pharmacol Res. 2008 Nov-Dec; 58(5-6):323-31. PMID: 18840529.
      Citations:    
    59. Cooper CR, Graves B, Pruitt F, Chaib H, Lynch JE, Cox AK, Sequeria L, van Golen KL, Evans A, Czymmek K, Bullard RS, Donald CD, Sol-Church K, Gendernalik JD, Weksler B, Farach-Carson MC, Macoska JA, Sikes RA, Pienta KJ. Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha. J Cell Biochem. 2008 Aug 15; 104(6):2298-309. PMID: 18561328.
      Citations:    
    60. Montie J, Faerber G, Schaeffer A, Steers W, Liebert M, Stoll D, Macoska J. Urology residency and research: round table discussion and plea for innovation. Urology. 2008 May; 71(5):762-5; discussion 765-6. PMID: 18295864.
      Citations:    
    61. Macoska JA, Begley LA, Dunn RL, Siddiqui J, Wei JT, Sarma AV. Pilot and feasibility study of serum chemokines as markers to distinguish prostatic disease in men with low total serum PSA. Prostate. 2008 Mar 01; 68(4):442-52. PMID: 18196514.
      Citations:    
    62. Begley LA, Kasina S, Mehra R, Adsule S, Admon AJ, Lonigro RJ, Chinnaiyan AM, Macoska JA. CXCL5 promotes prostate cancer progression. Neoplasia. 2008 Mar; 10(3):244-54. PMID: 18320069.
      Citations:    
    63. Demichelis F, Greulich H, Macoska JA, Beroukhim R, Sellers WR, Garraway L, Rubin MA. SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines. Nucleic Acids Res. 2008 Apr; 36(7):2446-56. PMID: 18304946.
      Citations:    
    64. Sarma AV, Burke JP, Jacobson DJ, McGree ME, St Sauver J, Girman CJ, Lieber MM, Herman W, Macoska J, Montie JE, Jacobsen SJ. Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men. Diabetes Care. 2008 Mar; 31(3):476-82. PMID: 18071006.
      Citations:    
    65. Begley LA, MacDonald JW, Day ML, Macoska JA. CXCL12 activates a robust transcriptional response in human prostate epithelial cells. J Biol Chem. 2007 Sep 14; 282(37):26767-26774. PMID: 17631494.
      Citations:    
    66. Macoska JA. Ancestry, genetic susceptibility, E-cadherin-160A and prostate cancer risk-is there an association? J Urol. 2006 Aug; 176(2):435-6. PMID: 16813859.
      Citations:    
    67. Barrett JM, Rovedo MA, Tajuddin AM, Jilling T, Macoska JA, MacDonald J, Mangold KA, Kaul KL. Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFbeta and its receptor, TGFbetaRII. Prostate. 2006 May 01; 66(6):632-50. PMID: 16388503.
      Citations:    
    68. Begley L, Keeney D, Beheshti B, Squire JA, Kant R, Chaib H, MacDonald JW, Rhim J, Macoska JA. Concordant copy number and transcriptional activity of genes mapping to derivative chromosomes 8 during cellular immortalization in vitro. Genes Chromosomes Cancer. 2006 Feb; 45(2):136-46. PMID: 16235240.
      Citations:    
    69. Begley L, Monteleon C, Shah RB, Macdonald JW, Macoska JA. CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro. Aging Cell. 2005 Dec; 4(6):291-8. PMID: 16300481.
      Citations:    
    70. Macoska JA, Paris P, Collins C, Andaya A, Beheshti B, Chaib H, Kant R, Begley L, MacDonald JW, Squire JA. Evolution of 8p loss in transformed human prostate epithelial cells. Cancer Genet Cytogenet. 2004 Oct 01; 154(1):36-43. PMID: 15381370.
      Citations:    
    71. Ray ME, Yang ZQ, Albertson D, Kleer CG, Washburn JG, Macoska JA, Ethier SP. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res. 2004 Jan 01; 64(1):40-7. PMID: 14729606.
      Citations:    
    72. Chaib H, MacDonald JW, Vessella RL, Washburn JG, Quinn JE, Odman A, Rubin MA, Macoska JA. Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors. Genes Chromosomes Cancer. 2003 Jul; 37(3):306-13. PMID: 12759929.
      Citations:    
    73. Corey E, Quinn JE, Buhler KR, Nelson PS, Macoska JA, True LD, Vessella RL. LuCaP 35: a new model of prostate cancer progression to androgen independence. Prostate. 2003 Jun 01; 55(4):239-46. PMID: 12712403.
      Citations:    
    74. Donald CD, Sun CQ, Lim SD, Macoska J, Cohen C, Amin MB, Young AN, Ganz TA, Marshall FF, Petros JA. Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Lab Invest. 2003 Apr; 83(4):501-5. PMID: 12695553.
      Citations:    
    75. True LD, Buhler K, Quinn J, Williams E, Nelson PS, Clegg N, Macoska JA, Norwood T, Liu A, Ellis W, Lange P, Vessella R. A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49. Am J Pathol. 2002 Aug; 161(2):705-15. PMID: 12163395.
      Citations:    
    76. Lee YG, Macoska JA, Korenchuk S, Pienta KJ. MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia. 2002 Jul-Aug; 4(4):291-4. PMID: 12082544.
      Citations:    
    77. Macoska JA. The progressing clinical utility of DNA microarrays. CA Cancer J Clin. 2002 Jan-Feb; 52(1):50-9. PMID: 11814065.
      Citations:    
    Macoska's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (367)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _